Check out the latest news and press releases capturing Ranbaxy's accomplishments and happenings and events around the world.

Choose a year to retrieve the news archive  2008 2007 2006 2005 2004 2003 2002 2001 2000 1999

May 2008

Day : 12

RANBAXY & MERCK SIGN ANTI-INFECTIVE DRUG DISCOVERY AND DEVELOPMENT AGREEMENT

April 2008

Day : 25

RANBAXY RECEIVES FINAL US FDA APPROVAL TO MANUFACTURE AND MARKET CETIRIZINE HYDROCHLORIDE ORAL SOLUTION

Day : 22

Q1 2008 GLOBAL SALES AT USD 409 MN (RS 16,231 MN), + 15%

RANBAXY AND ORCHID ANNOUNCE STRATEGIC BUSINESS ALLIANCE

Day : 15

RANBAXY AND ASTRAZENECA REACH AGREEMENT IN ESOMEPRAZOLE PATENT LITIGATION

Day : 9

RANBAXY AND DBT COLLABORATE IN THE AREA OF NDDR

Day : 8

RANBAXY BECOMES FIRST FOREIGN GENERIC COMPANY TO DEVELOP A GENERIC PRODUCT INDEPENDENTLY OUTSIDE JAPAN AND RECEIVE AUTHORISATION FROM MHLW - JAPAN

Day : 3

RANBAXY LAUNCHES WORLDS FIRST BIO-GENERIC RECOMBINANT INJECTIBLE FOR THE TREATMENT OF OSTEOPOROSIS IN INDIA

March 2008

Day : 28

RANBAXY ANNUAL AUDITED RESULTS FOR YEAR 2007

Day : 18

RANBAXY TO INTRODUCE INERSAN BRAND IN INDIA AND NEPAL

February 2008

Day : 19

RANBAXY BOARD CLEARS SCHEME OF DE-MERGER OF NEW DRUG DISCOVERY RESEARCH UNIT

Day : 7

RANBAXY RECEIVES TENTATIVE APPROVAL TO MANUFACTURE AND MARKET ESOMEPRAZOLE MAGNESIUM DR CAPSULES IN USA

Day : 6

RANBAXY GAINS APPROVAL TO MANUFACTURE AND MARKET CEFUROXIME AXETIL FOR ORAL SUSPENSION IN USA

January 2008

Day : 21

RANBAXY ANNOUNCES SETTLEMENT OF POSSIBLE IMITREX ® LITIGATION WITH GLAXOSMITHKLINE

Day : 17

NET PROFIT FOR THE YEAR INCREASES 53% TO RS 7,901 MN

Day : 14

RANBAXY HONOURS INDIAN SCIENTISTS AND YOUNG SCIENCE SCHOLARS

Day : 11

RANBAXY ENTERS THE CHYAWANPRASH MARKET